Skip to content

Clinical trials

Phase 2 Generalized Anxiety Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Generalized Anxiety Disorder Phase: Phase 2 Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20031
20042
20052
20061
20086
20111
20121
20141
20161
20182
20191
20212
20222
20231
20244
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting8
Terminated3
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
AstraZeneca2
Engrail Therapeutics INC2
Intra-Cellular Therapies, Inc.2
Merck Sharp & Dohme LLC2
Pfizer2
University of California, Los Angeles2
University of Florida2
Anhui Medical University1
Biotie Therapies Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Generalized Anxiety Disorder38
Anxiety Disorders13
Phobia, Social6
Anxiety, Separation5
Alcoholism1
Major Depressive Disorder1
Mental Disorders1
Mood Disorders1
Obsessive-Compulsive Disorder1
Panic Disorder1

Trials

Showing 26 to 38 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.